| ||
| Facebook Share Price Plunges Again: Valuation Doubts Rise As Social Network's ... Huffington Post At that price the company has shed more than $19 billion in market capitalization from its $38-per-share offering price last week. Investors were still shaking their heads over the botched opening trading of Facebook when Reuters reported late Monday ... See all stories on this topic » | ||
| ||
| ||
| Prolonged Facebook stock slide could hurt California budget as state faces ... Washington Post California's budget could take a hit if Facebook's stock price keeps sliding. Gov. Jerry Brown previously estimated the state would generate between $1.4 billion and $1.9 billion over the next 13 months from taxes related to sales of Facebook stock. See all stories on this topic » | ||
| Facebook stock dips to $31 on third day of trading Washington Post On the company's third day of trading, shares closed at $31 , or 8.5 percent off of their opening bell price. Minutes before closing bell, Reuters reported that the social network had settled a lawsuit in federal court in San Jose, Calif., ... See all stories on this topic » | ||
| Regulators to Look Into Facebook IPO as Share Price Drops Voice of America Shares in the world's most popular social network were sold in an initial public offering Friday at $38 each. The price of Facebook stock has since dropped to $31 a share - more than 18 percent. The Reuters news agency reported Tuesday that analysts ... See all stories on this topic » | ||
| ||
| ||
| Inside Fumbled Facebook Offering Wall Street Journal The news came two weeks before Facebook kicked off its "roadshow" on May 7 to pitch its shares to large investors. One week into the roadshow, the company raised its price range for the share sale, to between $34 and $38, from $28 to $35. See all stories on this topic » | ||
|
| ||
| Analysts Unveil These New Share Price Targets Today | Wall St ... By info@wallstcheatsheet.com (Damien Hoffman) Wall St. Watchdog reveals information about companies for which stock analysts reiterated their ratings on May 22nd. Lowe's (NYSE:LOW): RBC Capital Mkts reiterated its rating of Outperform for this company and changed its price target from ... Wall St. Cheat Sheet | ||
| Analysis And Valuation: Johnson & Johnson, Pfizer, And Merck ... By Christopher Grosvenor However, share prices could decline in the coming months as economic headwinds impact valuations. The pharmaceutical industry is concentrated with strong pricing power. It is a mature industry with little growth, industry consolidation, and ... SeekingAlpha.com: Home Page |
Tip: Use site restrict in your query to search within a site (site:nytimes.com or site:.edu). Learn more.
Delete this alert.
Create another alert.
Manage your alerts.
No comments:
Post a Comment